Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy

Xun Jin,1,* Bingwen Zou,2,* Li Luo,1,* Chuanhong Zhong,3 Peilan Zhang,1 Hao Cheng,1 Yanfang Guo,1 Maling Gou1 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, 2Department of Thoracic Oncology, Cancer...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jin X, Zou B, Luo L, Zhong C, Zhang P, Cheng H, Guo Y, Gou M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Thioridazine Doxorubicin Co-delivery nanoparticles breast cancer; Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/a6088d9695b44c23b8fb97ecaa709ec7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a6088d9695b44c23b8fb97ecaa709ec7
record_format	dspace
spelling	oai:doaj.org-article:a6088d9695b44c23b8fb97ecaa709ec72021-12-02T02:31:35ZCodelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy1178-2013https://doaj.org/article/a6088d9695b44c23b8fb97ecaa709ec72016-09-01T00:00:00Zhttps://www.dovepress.com/codelivery-of-thioridazine-and-doxorubicin-using-nanoparticles-for-eff-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xun Jin,1,* Bingwen Zou,2,* Li Luo,1,* Chuanhong Zhong,3 Peilan Zhang,1 Hao Cheng,1 Yanfang Guo,1 Maling Gou1 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, 2Department of Thoracic Oncology, Cancer Center, West China Hospital, Medical School, Sichuan University, Chengdu, 3Department of Neurosurgery, The Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan Province, People’s Republic of China *These authors contributed equally to this work Abstract: Cancer chemotherapy can benefit from the combination of different anticancer drugs. Here, we prepared doxorubicin (Dox)- and thioridazine (Thio)-coloaded methoxy poly(ethylene glycol)-poly(L-lactic acid) (MPEG-PLA) nanoparticles (NPs) for breast cancer therapy. These NPs have an average particle size of 27 nm. The drug loading efficiencies of Thio and Dox are 4.71% and 1.98%, respectively. Compared to the treatment of Thio or Dox alone, the combination of Thio and Dox exhibited a synergistic effect in inhibiting the growth of 4T1 breast cancer cells in vitro. In addition, the Thio- and Dox-coloaded MPEG-PLA NPs could efficiently suppress the growth of breast cancer cells in vivo. This study suggests that Thio- and Dox-coloaded MPEG-PLA NPs might have potential applications in breast cancer treatment. Keywords: thioridazine, doxorubicin, codelivery, nanoparticles, breast cancerJin XZou BLuo LZhong CZhang PCheng HGuo YGou MDove Medical PressarticleThioridazineDoxorubicinCo-deliverynanoparticlesbreast cancer;Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 4545-4552 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Thioridazine Doxorubicin Co-delivery nanoparticles breast cancer; Medicine (General) R5-920
spellingShingle	Thioridazine Doxorubicin Co-delivery nanoparticles breast cancer; Medicine (General) R5-920 Jin X Zou B Luo L Zhong C Zhang P Cheng H Guo Y Gou M Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
description	Xun Jin,1,* Bingwen Zou,2,* Li Luo,1,* Chuanhong Zhong,3 Peilan Zhang,1 Hao Cheng,1 Yanfang Guo,1 Maling Gou1 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, 2Department of Thoracic Oncology, Cancer Center, West China Hospital, Medical School, Sichuan University, Chengdu, 3Department of Neurosurgery, The Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan Province, People’s Republic of China *These authors contributed equally to this work Abstract: Cancer chemotherapy can benefit from the combination of different anticancer drugs. Here, we prepared doxorubicin (Dox)- and thioridazine (Thio)-coloaded methoxy poly(ethylene glycol)-poly(L-lactic acid) (MPEG-PLA) nanoparticles (NPs) for breast cancer therapy. These NPs have an average particle size of 27 nm. The drug loading efficiencies of Thio and Dox are 4.71% and 1.98%, respectively. Compared to the treatment of Thio or Dox alone, the combination of Thio and Dox exhibited a synergistic effect in inhibiting the growth of 4T1 breast cancer cells in vitro. In addition, the Thio- and Dox-coloaded MPEG-PLA NPs could efficiently suppress the growth of breast cancer cells in vivo. This study suggests that Thio- and Dox-coloaded MPEG-PLA NPs might have potential applications in breast cancer treatment. Keywords: thioridazine, doxorubicin, codelivery, nanoparticles, breast cancer
format	article
author	Jin X Zou B Luo L Zhong C Zhang P Cheng H Guo Y Gou M
author_facet	Jin X Zou B Luo L Zhong C Zhang P Cheng H Guo Y Gou M
author_sort	Jin X
title	Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
title_short	Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
title_full	Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
title_fullStr	Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
title_full_unstemmed	Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
title_sort	codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/a6088d9695b44c23b8fb97ecaa709ec7
work_keys_str_mv	AT jinx codeliveryofthioridazineanddoxorubicinusingnanoparticlesforeffectivebreastcancertherapy AT zoub codeliveryofthioridazineanddoxorubicinusingnanoparticlesforeffectivebreastcancertherapy AT luol codeliveryofthioridazineanddoxorubicinusingnanoparticlesforeffectivebreastcancertherapy AT zhongc codeliveryofthioridazineanddoxorubicinusingnanoparticlesforeffectivebreastcancertherapy AT zhangp codeliveryofthioridazineanddoxorubicinusingnanoparticlesforeffectivebreastcancertherapy AT chengh codeliveryofthioridazineanddoxorubicinusingnanoparticlesforeffectivebreastcancertherapy AT guoy codeliveryofthioridazineanddoxorubicinusingnanoparticlesforeffectivebreastcancertherapy AT goum codeliveryofthioridazineanddoxorubicinusingnanoparticlesforeffectivebreastcancertherapy
_version_	1718402428969156608

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy

Ejemplares similares